COVID-19疫苗接种后癌症复发或加重

Parisa Soleimani, Sepideh Yadollahifarsani, M. Motieian, Mahshid Sadat Chenarani Moghadam, S. Alimohammadi, Azadeh Khayyat, Mohammad Ali Esmaeil pour, Sina Neshat, Narges Alsadat Marashi, Leila Mahmoodnia, Rohollah Masomi
{"title":"COVID-19疫苗接种后癌症复发或加重","authors":"Parisa Soleimani, Sepideh Yadollahifarsani, M. Motieian, Mahshid Sadat Chenarani Moghadam, S. Alimohammadi, Azadeh Khayyat, Mohammad Ali Esmaeil pour, Sina Neshat, Narges Alsadat Marashi, Leila Mahmoodnia, Rohollah Masomi","doi":"10.34172/npj.2023.10593","DOIUrl":null,"url":null,"abstract":"COVID-19 infection has been a global health issue in the past recent years and numerous topics are studied in order to discover its pathophysiology and potential side effects. The potential for disease recurrence following the administration of the COVID-19 vaccine is one of the issues that has recently attracted attention. Several studies have revealed that the COVID-19 vaccines, like other vaccines, may have side effects and, in some cases, they may even deteriorate the underlying illnesses, such as rheumatic diseases, autoimmune diseases, and cancers. The effectiveness and safety of the COVID-19 vaccine for patients with malignancies are one of the factors that are considered regarding this vaccine. Lymph node involvement, disease recurrence, and potential paraclinical changes after receiving the COVID-19 vaccine are some of the concerns of patients with malignancy. In this mini-review, we attempted to investigate cases of cancer recurrence or recovery as well as lymphadenopathy following vaccination.","PeriodicalId":16388,"journal":{"name":"Journal of Nephropharmacology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cancer recurrence or aggravation following COVID-19 vaccination\",\"authors\":\"Parisa Soleimani, Sepideh Yadollahifarsani, M. Motieian, Mahshid Sadat Chenarani Moghadam, S. Alimohammadi, Azadeh Khayyat, Mohammad Ali Esmaeil pour, Sina Neshat, Narges Alsadat Marashi, Leila Mahmoodnia, Rohollah Masomi\",\"doi\":\"10.34172/npj.2023.10593\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"COVID-19 infection has been a global health issue in the past recent years and numerous topics are studied in order to discover its pathophysiology and potential side effects. The potential for disease recurrence following the administration of the COVID-19 vaccine is one of the issues that has recently attracted attention. Several studies have revealed that the COVID-19 vaccines, like other vaccines, may have side effects and, in some cases, they may even deteriorate the underlying illnesses, such as rheumatic diseases, autoimmune diseases, and cancers. The effectiveness and safety of the COVID-19 vaccine for patients with malignancies are one of the factors that are considered regarding this vaccine. Lymph node involvement, disease recurrence, and potential paraclinical changes after receiving the COVID-19 vaccine are some of the concerns of patients with malignancy. In this mini-review, we attempted to investigate cases of cancer recurrence or recovery as well as lymphadenopathy following vaccination.\",\"PeriodicalId\":16388,\"journal\":{\"name\":\"Journal of Nephropharmacology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Nephropharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34172/npj.2023.10593\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nephropharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/npj.2023.10593","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

近年来,新冠肺炎感染一直是一个全球性的健康问题,为了发现其病理生理学和潜在的副作用,对许多主题进行了研究。新冠肺炎疫苗接种后疾病复发的可能性是最近引起关注的问题之一。几项研究表明,新冠肺炎疫苗与其他疫苗一样,可能会产生副作用,在某些情况下,甚至可能恶化潜在疾病,如风湿性疾病、自身免疫性疾病和癌症。新冠肺炎疫苗对恶性肿瘤患者的有效性和安全性是该疫苗考虑的因素之一。接受新冠肺炎疫苗后,淋巴结受累、疾病复发和潜在的临床旁变化是恶性肿瘤患者的一些担忧。在这篇小型综述中,我们试图调查癌症复发或恢复的病例,以及接种疫苗后的淋巴结病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Cancer recurrence or aggravation following COVID-19 vaccination
COVID-19 infection has been a global health issue in the past recent years and numerous topics are studied in order to discover its pathophysiology and potential side effects. The potential for disease recurrence following the administration of the COVID-19 vaccine is one of the issues that has recently attracted attention. Several studies have revealed that the COVID-19 vaccines, like other vaccines, may have side effects and, in some cases, they may even deteriorate the underlying illnesses, such as rheumatic diseases, autoimmune diseases, and cancers. The effectiveness and safety of the COVID-19 vaccine for patients with malignancies are one of the factors that are considered regarding this vaccine. Lymph node involvement, disease recurrence, and potential paraclinical changes after receiving the COVID-19 vaccine are some of the concerns of patients with malignancy. In this mini-review, we attempted to investigate cases of cancer recurrence or recovery as well as lymphadenopathy following vaccination.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Nephropharmacology
Journal of Nephropharmacology Medicine-Pharmacology (medical)
CiteScore
1.70
自引率
0.00%
发文量
18
审稿时长
4 weeks
期刊最新文献
Evaluation of the effect of montelukast drug in improving the clinical condition of patients with COVID-19 in referral hospitals in Isfahan; a randomized clinical trial Renal insufficiency in breast cancer patients; a review study The Mayo Clinic consensus report on membranous nephropathy; a promising step toward better treating the disease Emerging cancer in individuals with cardiovascular disease: Exploring the intersection of reverse cardio-oncology and nephropharmacology Oncocardiology: close collaboration between oncologists, cardiologists, and nephrologists
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1